Eli Lilly to increase production capacity at pharmaceutical packaging plant in São Paulo through investment of approximately US$6.4M; company will replace four production lines by late 2014, buy new equipment and improve, adapt, expand facilities

Elyse Blye

Elyse Blye

LONDON , March 4, 2014 () – US-based drugmaker Eli Lilly will invest around BRL15mn (US$6.4mn) over the next two years in Brazil, reports rcmpharma.com. The company will use the investment to renovate its packaging division at its plant in São Paulo. Its four production lines will be changed by late 2014 to help increase the plant's production capacity. The investment will also be used to buy new equipment, improve, adapt and expand its facilities and improve the packaging of the company's pills and medicines.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.